Results 71 to 80 of about 10,645 (216)

A Comparative Histopathologic Analysis of Prostatic Carcinomas by Conventional and 2005 ISUP Modified Gleason Systems [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: The Gleason system is one of the most widely used systems for grading prostatic carcinomas. With several revisions since its inception, earlier studies have found poor levels of agreement between core biopsy and radical prostatectomy ...
Deborah Dalmeida, T Umashankar, Crysle Saldanha   +2 more
doaj   +1 more source

Relationship of Ki67, TP53, MDM-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades, tumor category and overall patient survival in urothelial tumors of the bladder.

, 2008
Using the 1998 World Health Organization/International Society of Urological Pathology (WHO/ISUP) (2004 WHO), 1999 WHO/ISUP, and 1973 WHO classifications, we examined Ki67, BCL-2, TP53, and MDM-2 expressions in invasive and noninvasive urothelial ...
Akyuerek, Nalan, IŞIK GÖNÜL, İPEK, DURSUN, AYŞE, Kuepeli, Bora   +3 more
core   +1 more source

Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations

, 2014
During the last 30years many advances have been made in kidney tumor pathology. In 1981, 9 entities were recognized in the WHO Classification. In the latest classification of 2004, 50 different types have been recognized.
McKenney J, Rioux Leclercq N, Hes O, Srigley J, Netto G, MARTIGNONI, Guido, Humphrey P, Tickoo S, Ferran A, Magi Galluzzi C, Merino M, Delahunt B, Montironi R, Argani P, Tan PH, Billis A, Cheng L, Mahul A, Egevad L, Shen S, Epstein J, Grignon D, Moch H, Zhou M, Bonsib S, Tamboli P, Cheville J, Trpkov K, Eble J, Comperat E., Reuter V, Samaratunga H   +31 more
core   +2 more sources

Oncological and continence outcomes after nerve‐sparing robot‐assisted radical prostatectomy in selected STAMPEDE‐defined high‐risk prostate cancer

BJU International, EarlyView.
Objectives To examine the association between the nerve‐sparing (NS) technique applied during radical prostatectomy (RP) and early oncological and continence outcomes in patients with Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE)‐defined high‐risk prostate cancer (PCa) undergoing robot‐assisted RP ...
Andreia Bilé‐Silva, Prabhakar Rajan, Benjamin Lamb, Mehmet Özalevli, Louise Dickinson, Justin Collins, Anand Kelkar, John Kelly, Senthil Nathan, Greg Shaw, Prasanna Sooriakumaran, Ashwin Sridhar, Zafer Tandogdu   +12 more
wiley   +1 more source

The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy

BMC Urology, 2021
Background To investigate the role of mpMRI and high PIRADS score as independent triggers in the qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy.
Łukasz Nyk, Omar Tayara, Tomasz Ząbkowski, Piotr Kryst, Aneta Andrychowicz, Wojciech Malewski   +5 more
doaj   +1 more source

Transurethral ultrasound ablation (TULSA) for prostate cancer: a systematic review and meta‐analysis

BJU International, EarlyView.
Objective Our objective was to synthesise evidence on oncological, functional and safety outcomes of magnetic resonance imaging‐guided transurethral ultrasound ablation (TULSA) for primary and recurrent prostate cancer. Methods MEDLINE, Embase, Web of Science and Scopus were systematically searched from inception to July 2025. The primary outcomes were
Eugene Wang, Xinyi Wei, Yajat Dua, Marlon Perera, Jeremy Grummet   +4 more
wiley   +1 more source

Segment‐based comparison of multiparametric MRI, Gallium‐68‐PSMA‐PET/CT and combined imaging with histopathology in prostate cancer

BJU International, EarlyView.
Objectives To compare the segment‐based diagnostic performance of multiparametric magnetic resonance imaging (mpMRI), Gallium‐68‐prostate‐specific membrane antigen‐positron emission tomography/computed tomography (68Ga‐PSMA‐PET/CT), for detecting histopathologically confirmed prostate cancer (PCa).
Clarissa J. Schmidt, Marit Bernhardt, Glen Kristiansen, Florian C. Gaertner, Barbara Kreppel, Markus Essler, Julian A. Luetkens, Ulrike Attenberger, Michael Anspach, Carsten‐Henning Ohlmann, Stefan Hauser, Jörg Ellinger, Manuel Ritter, Philipp Krausewitz   +13 more
wiley   +1 more source

p16 Overexpression and Human Papillomavirus Positivity in More Than 1000 Penile Cancers

International Journal of Cancer, Volume 159, Issue 12, Page 3029-3037, 15 December 2026.
ABSTRACT Penile cancer is a severe disease, and a large proportion is related to high‐risk (hr) human papillomavirus (HPV). P16 is used as an immunohistochemical marker of HPV in clinical diagnostics. Population‐based data on the prevalence of p16 in penile cancer is scarce.
Marianne Gardar Stærk, Birgitte Grønkær Toft, Christina Stilling, Johanna Elversang, Sanne Kjær‐Frifeldt, Sonja Höhle Hjulskov, Sanja Stifter‐Vretenar, Marie Aarslev Schou, Mikael Aagaard, Peter Meidahl Petersen, Jakob Kristian Jakobsen, Christian Munk, Susanne Krüger Kjær   +12 more
wiley   +1 more source

Basal total testosterone serum levels predict biopsy and pathological ISUP grade group in a large cohort of Caucasian prostate cancer patients who underwent radical prostatectomy

Therapeutic Advances in Urology, 2020
Aims: The study aimed to evaluate associations of preoperative total testosterone (TT) with the risk of aggressive prostate cancer (PCA). Materials & methods: From 2014 to 2018, basal TT levels were measured in 726 consecutive PCA patients. Patients were
Alessandro Tafuri, Marco Sebben, Riccardo Rizzetto, Nelia Amigoni, Aliasger Shakir, Tania Processali, Marco Pirozzi, Alessandra Gozzo, Katia Odorizzi, Mario De Michele, Sebastian Gallina, Alberto Bianchi, Paola Irene Ornaghi, Matteo Brunelli, Filippo Migliorini, Maria Angela Cerruto, Salvatore Siracusano, Walter Artibani, Alessandro Antonelli, Antonio B. Porcaro   +19 more
doaj   +1 more source

The PART randomised trial protocol: Partial Ablation versus Radical Treatment for prostate cancer

BJU International, Volume 138, Issue 6, Page 1013-1024, December 2026.
Objectives Primary objective: to determine whether prostate gland partial ablation (PA) has non‐inferior oncological treatment success vs radical treatment (RT) of localised intermediate‐risk prostate cancer (irPCa). Secondary objectives: to compare (i) participant‐reported urinary and sexual dysfunction side effects, (ii) short/medium term serious ...
Richard J. Bryant, Tom Leslie, Marc Laniado, Abhishek Sharma, Alistair Grey, John Withington, Christopher Blick, Edward Streeter, Sanjeev Kotwal, Oliver Hulson, William Cross, Daniel W. Good, Altan Omer, Taimur T. Shah, Nishant Bedi, Luke Stroman, Caroline Moore, Prasanna Sooriakumaran, Hashim U. Ahmed, Simon F. Brewster, Vicki S. Barber, Aimi Hewitt, Clare Calvert, Jessica Scaife, Derek Shepherd, Filipa Landeiro, Jane Wolstenholme, Philip Camilleri, Clare Verrill, Shelagh Lovell, Martin Pirkl, Fergus Gleeson, Roxanne Williams, Jo Cook, Catherine R. Holt, Martyn Hill, Jonathan Cook, James Radford, Ioana R. Marian, Ruth Macpherson, Daisy Elliott, Jenny L. Donovan, Freddie C. Hamdy   +42 more
wiley   +1 more source